Zeolite Nanoparticles Loaded with 2-Methoxystradiol as a Novel Drug Delivery System for the Prostate Cancer Therapy
International Journal of Molecular Sciences · 2023
DOI: 10.3390/ijms241310967 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Denisse Mena-Silva und 9 weiteren Autor:innen. Beteiligte Einrichtung: Laboratorio de Inmunología de la Reproducción, Facultad de Química y Biología, Universidad de Santiago de Chile, Santiago 9160000, Chile. Hauptthemen laut MEDLINE: Zeolites, Prostatic Neoplasms, Nanoparticles. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Dirección de Investigación Cientifica y Tecnológica (DICYT), Basal Program for Centers of Excellence.
Abstract (Originalsprache)
The estrogen metabolite 2-methoxyestradiol (2ME) is a promissory anticancer drug mainly because of its pro-apoptotic properties in cancer cells. However, the therapeutic use of 2ME has been hampered due to its low solubility and bioavailability. Thus, it is necessary to find new ways of administration for 2ME. Zeolites are inorganic aluminosilicates with a porous structure and are considered good adsorbents and sieves in the pharmaceutical field. Here, mordenite-type zeolite nanoparticles were loaded with 2ME to assess its efficiency as a delivery system for prostate cancer treatment. The 2ME-loaded zeolite nanoparticles showed an irregular morphology with a mean hydrodynamic diameter of 250.9 ± 11.4 nm, polydispersity index of 0.36 ± 0.04, and a net negative surface charge of −34 ± 1.73 meV. Spectroscopy with UV-vis and Attenuated Total Reflectance Infrared Fourier-Transform was used to elucidate the interaction between the 2ME molecules and the zeolite framework showing the formation of a 2ME-zeolite conjugate in the nanocomposite. The studies of adsorption and liberation determined that zeolite nanoparticles incorporated 40% of 2ME while the liberation of 2ME reached 90% at pH 7.4 after 7 days. The 2ME-loaded zeolite nanoparticles also decreased the viability and increased the mRNA of the 2ME-target gene F-spondin, encoded by SPON1, in the human prostate cancer cell line LNCaP. Finally, the 2ME-loaded nanoparticles also decreased the viability of primary cultures from mouse prostate cancer. These results show the development of 2ME-loaded zeolite nanoparticles with physicochemical and biological properties compatible with anticancer activity on the human prostate and highlight that zeolite nanoparticles can be a good carrier system for 2ME.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratorio de Inmunología de la Reproducción, Facultad de Química y Biología, Universidad de Santiago de Chile, Santiago 9160000, Chile.
- Centro para el Desarrollo de la Nanociencia y la Nanotecnología CEDENNA, Santiago 9160000, Chile.
- Faculty of Chemistry and Food Chemistry, Technische Universitat Dresden, Bergstrasse 66c, 01069 Dresden, Germany.
- Advanced Center for Chronic Diseases (ACCDIS), Facultad de Ciencias Químicas y Farmacéuticas y Universidad de Chile, Santiago 8380000, Chile.
- Laboratory of Nanomedicine and Targeted Delivery, School of Medicine, Universidad de Talca, Talca 3460000, Chile.
- Center for Nanomedicine, Diagnostic & Drug Development (cND3), Universidad de Talca, Talca 3460000, Chile.
ORCID-Profile: Emanuel Guajardo-Correa, Patricia Diaz, Cristian Vilos, Juliano C Denardin, Pedro A Orihuela
Förderung
- Dirección de Investigación Cientifica y Tecnológica (DICYT)
- Basal Program for Centers of Excellence
Zitieren
APA
Mena-Silva, D., Alfaro, A., León, A., Guajardo-Correa, E., Elgueta, E., Diaz, P., Vilos, C., Cardenas, H., Denardin, J. C., & Orihuela, P. A. (2023). Zeolite Nanoparticles Loaded with 2-Methoxystradiol as a Novel Drug Delivery System for the Prostate Cancer Therapy. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms241310967
Vancouver
Mena-Silva D, Alfaro A, León A, Guajardo-Correa E, Elgueta E, Diaz P, et al. Zeolite Nanoparticles Loaded with 2-Methoxystradiol as a Novel Drug Delivery System for the Prostate Cancer Therapy. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms241310967
BibTeX
@article{MenaSilva2023,
author = {Mena-Silva, Denisse and Alfaro, Aline and León, Andrea and Guajardo-Correa, Emanuel and Elgueta, Estefania and Diaz, Patricia and Vilos, Cristian and Cardenas, Hugo and Denardin, Juliano C and Orihuela, Pedro A},
title = {Zeolite Nanoparticles Loaded with 2-Methoxystradiol as a Novel Drug Delivery System for the Prostate Cancer Therapy},
journal = {International Journal of Molecular Sciences},
year = {2023},
doi = {10.3390/ijms241310967}
}
EUVIMED